Peter Bisgaard

Peter Bisgaard is on these Sector & Stage Rankings

Peter Bisgaard's Investments On Record (10)

Company	StageDateRound Size	Total Raised
Engrail Therapeutics	Series BMar 2024$160M Series AAug 2021$32M Series AJun 2020$32M	$220M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Jasper Bos (Forbion), Niall O’Donnell (RiverVest), Heath Lukatch (Red Tree Venture Capital)
Oculis	Series CMay 2021$57M Series BJan 2019$16M	$190M
Co-investors: Rob Hopfner (Pivotal bioVenture Partners), Lionel Carnot (Earlybird Venture Capital), Florent Gros (Earlybird Venture Capital), Zhi Yang (BVCF (Bioveda China Fund))
Eargo	Series EJul 2020$82M Series DMar 2019$52M Series COct 2017$45M	$220M
Co-investors: Josh Makower (New Enterprise Associates (NEA)), David Wu (Maveron), Ben Capell (Peterson Ventures), Pierre Lamond (Eclipse Ventures), Juliet Tammenoms Bakker (Longitude Capital), Farzad Nazem
OncXerna Therapeutics	Series BJun 2019$80M	$80M
Ceterix Orthopaedics	Series BMay 2014$18M	$18M
Co-investors: Charles Warden (Versant Ventures)
Otonomy	Series DApr 2014$49M Series CSep 2013$46M Series BAug 2010$39M Series BAug 2010$39M	$180M
Co-investors: Chau Khuong (OrbiMed), Brian Dovey (Domain Associates), John McKearn (RiverVest), Niall O’Donnell (RiverVest), Jay Lichter (Avalon Ventures), Bill Harrington (Osage University Partners), Heather Preston
Nevro	Series CMar 2013$48M	$130M
Co-investors: Paul Klingenstein (Aberdare Ventures), Asish Xavier (Johnson & Johnson Innovation)
Alder Biopharmaceuticals	Series DApr 2012$38M	$78M
Co-investors: Heather Preston

Peter Bisgaard's Experience